Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · IEX Real-Time Price · USD
2.650
-0.040 (-1.49%)
At close: May 1, 2024, 4:00 PM
2.940
+0.290 (10.94%)
After-hours: May 1, 2024, 7:43 PM EDT
Intelligent Bio Solutions Revenue
Intelligent Bio Solutions had revenue of $2.88M in the twelve months ending December 31, 2023, with 140.61% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $917.27K with 46.46% year-over-year growth. In the fiscal year ending June 30, 2023, Intelligent Bio Solutions had annual revenue of $1.99M with 356.25% growth.
Revenue (ttm)
$2.88M
Revenue Growth
+140.61%
P/S Ratio
2.62
Revenue / Employee
$56,473
Employees
51
Market Cap
7.54M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2023 | 1.99M | 1.56M | 356.25% |
| Jun 30, 2022 | 437.15K | -1.54M | -77.93% |
| Jun 30, 2021 | 1.98M | 1.79M | 949.30% |
| Jun 30, 2020 | 188.74K | 188.56K | 100,295.74% |
| Jun 30, 2019 | 188.00 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| XWELL | 30.11M |
| Precipio | 15.20M |
| Vivos Therapeutics | 13.80M |
| Plus Therapeutics | 4.91M |
| Kazia Therapeutics | 15.65K |
INBS News
- 13 days ago - Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results - GlobeNewsWire
- 20 days ago - Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge Reader - GlobeNewsWire
- 5 weeks ago - Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC - GlobeNewsWire
- 7 weeks ago - Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 7 weeks ago - Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 2024 - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders' Equity Requirement - GlobeNewsWire